EQUASENS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58 EUR | -2.52% |
|
-0.17% | -5.07% |
| 04-02 | Equasens : RNPG virtually stable in 2023 | CF |
| 03-29 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
| Sales 2023 | 220M 235M 18.81B | Sales 2024 * | 231M 247M 19.82B | Capitalization | 872M 932M 74.66B |
|---|---|---|---|---|---|
| Net income 2023 | 47M 50.25M 4.02B | Net income 2024 * | 49M 52.39M 4.2B | EV / Sales 2023 | 4.18 x |
| Net cash position 2023 * | 35.92M 38.41M 3.08B | Net cash position 2024 * | 64.17M 68.61M 5.49B | EV / Sales 2024 * | 3.49 x |
| P/E ratio 2023 |
19.5
x | P/E ratio 2024 * |
17.4
x | Employees | - |
| Yield 2023 * |
2.09% | Yield 2024 * |
2.3% | Free-Float | 32.43% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.52% | ||
| 1 week | -0.17% | ||
| Current month | +13.06% | ||
| 1 month | +13.28% | ||
| 3 months | +9.43% | ||
| 6 months | -12.12% | ||
| Current year | -5.07% |
1 week
57.10
60.60
1 month
50.0061.80
Current year
46.1561.80
1 year
46.1585.80
3 years
46.15103.00
5 years
41.25124.20
10 years
17.43124.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 31/12/90 | |
Thierry Chapusot
FOU | Founder | 65 | 24/01/96 |
| Director of Finance/CFO | - | 31/12/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 24/01/96 |
| Director/Board Member | 46 | 26/06/17 | |
| Director/Board Member | 59 | 31/12/99 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 58 | -2.52% | 4,466 |
| 25/04/24 | 59.5 | +0.17% | 7,484 |
| 24/04/24 | 59.4 | -0.67% | 4,313 |
| 23/04/24 | 59.8 | +3.64% | 8,055 |
| 22/04/24 | 57.7 | -0.69% | 9,086 |
Real-time Euronext Paris, April 26, 2024 at 04:35 pm
More quotes
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows:
- pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;
- publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);
- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).
Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
Sector
IT Services & Consulting
Calendar
06/05/2024
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
58
EUR
Average target price
71.25
EUR
Spread / Average Target
+22.84%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.07% | 931M | |
| -12.23% | 194B | |
| +0.74% | 166B | |
| +2.19% | 153B | |
| +4.34% | 99.85B | |
| +7.04% | 77.56B | |
| +19.09% | 73.55B | |
| -7.30% | 71B | |
| -20.54% | 52.81B | |
| +0.53% | 47.86B |
- Stock Market
- Equities
- EQS Stock
